Exosomal miRNA‐215‐5p Derived from Adipose‐Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting <i>ZEB2</i>

Abstract

ADSCs-Exo has the protective effect on HG-evoked EMT progression of podocytes thru a mechanism involving ZEB2. Potentially, the ADSCs-Exo preparation is a useful therapeutic strategy for improving podocyte dysfunction and DN symptoms clinically.